ArticleBiomedicines2023

DCLK1 Drives EGFR-TKI-Acquired Resistance in Lung Adenocarcinoma by Remodeling the Epithelial-Mesenchymal Transition Status.

Rui Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.